The oral administration of Δ9-tetrahydrocannabinol (THC) may treat both spasticity and pain associated with multiple sclerosis. This is according to a study being published by the journal Clinical Therapeutics, and e-published ahead of print by the U.S. National Institute of Health. According to the Mayo Clinic, multiple sclerosis (MS) is a “disease in which the …
Tag: Spasticity treatment
- clinical therapeutics, Mayo Clinic, ms, ms cannabis, ms marijuana, ms treatment, ms weed, multiple sclerosis, Multiple Sclerosis cannabis, Multiple Sclerosis marijuana, Multiple Sclerosis treatment, Multiple Sclerosis weed, national institute of health, spasticity, Spasticity cannabis, Spasticity marijuana, Spasticity treatment, Spasticity weed
- Here Are the 5 States Most Likely to Legalize Marijuana Next
- Medical Cannabis Use Associated With Reduced Opioid Use In Pain Patients, Finds Study
- Study: Marijuana Stores Associated With Increased Home Values
- U.S. Congress Approves Bill to Legalize Hemp, Sending it to President Trump
- New Zealand Parliament Approves Medical Marijuana Legislation
- California Officials Say Cannabis Deliveries Can Be Made Anywhere, Even in Cities Where Marijuana is Banned
- U.S. Surgeon General Says We Need to Reconsider How We Schedule Marijuana
- Study: CBD Reduces Airway Inflammation and Fibrosis in Experimental Allergic Asthma.
Thank you for reading TheJointBlog.com!